1 |
So, H. S., C. Park, H. J. Kim, J. H. Lee, S. Y. Park, J. H. Lee, Z. W. Lee, H. M. Kim, F. Kalinec, D. J. Lim and R. Park. 2005. Protective effect of T-type calcium channel blocker flunarizine on cisplatin-induced death of auditory cells. Hearing Research 204, 127-139
DOI
ScienceOn
|
2 |
So, H., H. Kim, J. H. Lee, C. Park, Y. Kim, E. Kim, J. K. Kim, K. J. Yun, K. M. Lee, H. Y. Lee, S. K. Moon, D. J. Lim and R. Park. 2007. Cisplatin cytotoxicity of auditory cells requires secretions of proinflammatory cytokines via activation of ERK and NF-kappaB. J. Assoc. Res. Otolaryngol. 8, 338-355
DOI
ScienceOn
|
3 |
Strock, M., M. Schilling, K. Burkhardt, R. Prestel, D. Abendroth and C. Hamme. 1994. Production of proinflammatory cytokine and adhension molecules in ex-vivo xenogeneic Kidney perfusion. Transpl. Int. 1, S647-S649
|
4 |
Teranishi, M., T. Nakashima and T. Wakabayashi. 2001. Effects of alphatocopherol on cisplatin-induced ototoxicity in guinea pigs. Hearing Research 151, 61-70
DOI
ScienceOn
|
5 |
Yang, C. S., H. M. Lee, J. Y. Lee, J. A. Kim, S. J. Lee, D. M. Shin, Y. H. Lee, D. S. Lee, J. El-Benna and E. K. Jo. 2007. Reactive oxygen species and p47phox activation are essential for the Mycobacterium tuberculosis-induced pro-inflammatory response in murine microglia. J. Neuroinflammation 4, 27
DOI
ScienceOn
|
6 |
Laurell, G. and S. D. Batter. 1991. Degeneration of the organ of Corti following intravenous administration of cisplatin. Acta. Otolaryngol. 111, 891-898
DOI
ScienceOn
|
7 |
Kopke, R. D., W. Liu, R. Gabaizad, A. Jacono, J. Feghali, D. Spray, P. Garcia, H. Steinman, B. Malgrange, R. J. Ruben, L. Rybak and T. R. Van De Water. 1997. Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells. AM. J. Otol. 18, 559-571
|
8 |
Kartalou, M. and J. M. Essigmann. 2001. Mechanism of resistance to cisplatin. Mutat. Res. 478, 23-43
DOI
ScienceOn
|
9 |
Kathleen, C. M., L. P. Campbell, R. P. Rybak and L. H. Meech. 1996. D-Methionine provides excellent protection from cisplatin ototoxicity in the rat. Hearing Research 102, 90-98
DOI
ScienceOn
|
10 |
Hikiji, H., W. S. Shin, T. Koizumi, T. Takato, T. Susami, Y. Koizumi, Y. Okai-Matsuo and T. Toyo-Oka. 2000. Peroxynitrite production by TNF-alpha and IL-1beta: implication for suppression of osteoblastic differentiation. Am. J. Physiol. Endocrinol. Metab. 278, E1031-E1037
DOI
|
11 |
Jordan, P. and M. Carmo-Fonseca. 2000. Molecular mechanism involved in cisplatin cytotoxicity. Cell Mol. Life Sci. 57, 1229-1235
DOI
ScienceOn
|
12 |
Kalinec, G. M., P. Webster, D. J. Lim and F. Kalinec. 2003. A cochlear cell line as an in vitro system for drug ototoxicity screening. Audiol. Neurootol. 8, 177-189
DOI
ScienceOn
|
13 |
Zhang, B., G. Ramesh, C. C. Norbury and W. B. Reeves. 2007. Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells. Kidney Int. 72, 37-44
DOI
ScienceOn
|
14 |
Watanabe, K. C., K. Jinnouchi, A. Hess, O. Michel, S. Baba and T. Yagi. 2002. Carboplatin induces less apoptosis in the cochlea of guinea pigs than cisplatin. Chemotherapy 48, 82-87
DOI
ScienceOn
|
15 |
Feghali, J. G., W. Liu and T. R. Van De Water. 2001. L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity. Laryngoscope. 111, 1147-1155
|
16 |
Fujinobu, T., C. A. Whitworth and L. P. Rybak. 2003. Influence of PH on the ototoxicity of cisplatin: a round window application study. Hearing Research 177, 21-31
DOI
ScienceOn
|
17 |
Ding, D., A. Stracher and R. J. Salvi. 2002. Leupeptin protects cochlear and vestibular hair cells from gentamicin ototoxicity. Hearing Research 164, 115-126
DOI
ScienceOn
|
18 |
Alam, S. A., K. Ikeda, T. Oshima, M. Suzuki, T. Kawase, T. Kikuchi and T. Takasaka. 2000. Cisplatin-induced apoptotic cell death in Mongolian gerbil cochlea. Hearing Research 141, 28-38
DOI
ScienceOn
|
19 |
Estrem, S. A., R. W. Babin, J. H. Ryu and K. C. Moore. 1981. Cis-diamminedichloroplatinum (II) ototoxicity in the guinea pig. Otolaryngol. Head. Neck. Surg. 90, 638-645
|
20 |
Farm, R. J. 1992. Cisplatin and platinum analogues: recent advances. Curr. Opin. Oncol. 4, 1073-1079
DOI
ScienceOn
|
21 |
Brueckmann, M., T. Bertsch, S. Lang, T. Sueselbeck, C. Wlopert, J. J. Kaden, C. Jaramillo, G. Huhel, M. Borggrefe and K. K. Haase. 2004. Time course of systemic markers of inflammation in patients presenting with acute coronary syndromes. Clin. Chem. Lab. Med. 42, 1132-1139
DOI
ScienceOn
|
22 |
Prasad, D., S. Michelle, M. C. Patricia, M. S. Park, E. C. Nora, G. Kalinec and F. Kalinec. 2002. Cisplatin-induced apoptois in auditory cells: role of dath receptor and mitochondrial pathways. Hearing Research 174, 45-54
DOI
ScienceOn
|
23 |
Rybak L. P., K. Husain, C. Whitworth and S. M. Somani. 1999. Dose dependent protection by lipoic acid against cisplatin- induced ototoxicity in rats: Antioxodant defense system. Toxicological Sciences 47, 195-202
DOI
ScienceOn
|